These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21624839)

  • 21. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
    Burton CM; Carlsen J; Mortensen J; Andersen CB; Milman N; Iversen M
    J Heart Lung Transplant; 2007 Jul; 26(7):681-6. PubMed ID: 17613397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor-2 maintains the differentiation potential of nucleus pulposus cells in vitro: implications for cell-based transplantation therapy.
    Tsai TT; Guttapalli A; Oguz E; Chen LH; Vaccaro AR; Albert TJ; Shapiro IM; Risbud MV
    Spine (Phila Pa 1976); 2007 Mar; 32(5):495-502. PubMed ID: 17334282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration.
    Tufvesson E; Westergren-Thorsson G
    J Cell Sci; 2003 Dec; 116(Pt 23):4857-64. PubMed ID: 14600270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
    Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
    J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular glycosaminoglycan changes in healthy and overgrown gingiva fibroblasts after cyclosporin A and cytokine treatments.
    Stabellini G; Calastrini C; Mariani G; Gioia M; Caramelli E; Gagliano N; Dellavia C; Moscheni C; Vizzotto L; Calvi EM
    J Oral Pathol Med; 2004 Jul; 33(6):346-53. PubMed ID: 15200483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.
    Larsson-Callerfelt AK; Hallgren O; Andersson-Sjöland A; Thiman L; Björklund J; Kron J; Nihlberg K; Bjermer L; Löfdahl CG; Westergren-Thorsson G
    Respir Res; 2013 Feb; 14(1):21. PubMed ID: 23406566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1.
    Nonaka M; Pawankar R; Fukumoto A; Yagi T
    Clin Exp Allergy; 2008 May; 38(5):812-21. PubMed ID: 18355371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients.
    Ward C; Forrest IA; Murphy DM; Johnson GE; Robertson H; Cawston TE; Fisher AJ; Dark JH; Lordan JL; Kirby JA; Corris PA
    Thorax; 2005 Oct; 60(10):865-71. PubMed ID: 15972366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation.
    Harvey KA; Paranavitana CN; Zaloga GP; Siddiqui RA
    J Cell Physiol; 2007 May; 211(2):353-63. PubMed ID: 17167780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix proteins from smoke-exposed fibroblasts are pro-proliferative.
    Krimmer DI; Burgess JK; Wooi TK; Black JL; Oliver BG
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):34-9. PubMed ID: 21778414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.
    Xu Z; Ramachandran S; Gunasekaran M; Zhou F; Trulock E; Kreisel D; Hachem R; Mohanakumar T
    J Heart Lung Transplant; 2015 Sep; 34(9):1154-62. PubMed ID: 25979625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
    Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of extracellular matrix composition on airway epithelial cell and fibroblast structure: implications for airway remodeling in asthma.
    Royce SG; Tan L; Koek AA; Tang ML
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):238-46. PubMed ID: 19354071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Larsson-Callerfelt AK; Müller C; Andersson-Sjöland A; Thiman L; Larsson H; Hallgren O; Bjermer L; Eriksson L; Westergren-Thorsson G
    Respir Med; 2020 May; 166():105944. PubMed ID: 32250877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
    Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
    J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
    Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
    J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.